Publications by authors named "Francesco Ingenito"

Claim this Profile
T
Targeting Glioblastoma Stem Cells: A40s Aptamer-NIR-Dye Conjugate for Glioblastoma Visualization and Treatment.
Alessandra Affinito, Francesco Ingenito, Sara Verde, Emanuele Musella, Birlipta Pattanayak

Biomolecules· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ex.50.T aptamer impairs tumor-stroma cross-talk in breast cancer by targeting gremlin-1.
Cristina Quintavalle, Francesco Ingenito, Giuseppina Roscigno, Birlipta Pattanayak, Carla Lucia Esposito

Cell Death Discov· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An LC-MS/MS method for the determination of drugs of abuse included THC-COOH, EtG, and NPS, using a single hair extraction sample.
Valentina Longo, Giulia Stocchero, Manuela Lucchiari, Giovanni Michele Marchio, Flora Donini, Francesco Ingenito

Drug Test Anal· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MCT4-driven CAF-mediated metabolic reprogramming in breast cancer microenvironment is a vulnerability targetable by miR-425-5p.
Alessandra Affinito, Cristina Quintavalle, Rosario Vincenzo Chianese, Giuseppina Roscigno, Danilo Fiore, Francesco Ingenito

Cell Death Discov· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of two methods for the extraction of ethylglucuronide from hair.
Eleonora Groff, Manuela Lucchiari, Giulia Stocchero, Flora Donini, Giovanni Michele Marchio, Francesco Ingenito

Drug Test Anal· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Exosomal microRNAs synergistically trigger stromal fibroblasts in breast cancer.
Iolanda Scognamiglio, Lorenza Cocca, Ilaria Puoti, Francesco Palma, Francesco Ingenito

Mol Ther Nucleic Acids· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exosomal microRNAs synergistically trigger stromal fibroblasts in breast cancer.
Iolanda Scognamiglio, Lorenza Cocca, Ilaria Puoti, Francesco Palma, Francesco Ingenito

Mol Ther Nucleic Acids· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Proteomic Profiling of Secreted Extracellular Vesicles from Breast Fibroadenoma and Malignant Lesions: A Pilot Study.
Katia Pane, Cristina Quintavalle, Silvia Nuzzo, Francesco Ingenito, Giuseppina Roscigno

Int J Mol Sci· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-34c-3p targets CDK1 a synthetic lethality partner of KRAS in non-small cell lung cancer.
Francesco Palma, Alessandra Affinito, Silvia Nuzzo, Giuseppina Roscigno, Iolanda Scognamiglio, Francesco Ingenito

Cancer Gene Ther· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a novel RNA aptamer that selectively targets breast cancer exosomes.
Carla Lucia Esposito, Cristina Quintavalle, Francesco Ingenito, Deborah Rotoli, Giuseppina Roscigno

Mol Ther Nucleic Acids· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulating the Crosstalk between the Tumor and the Microenvironment Using SiRNA: A Flexible Strategy for Breast Cancer Treatment.
Giuseppina Roscigno, Iolanda Scognamiglio, Francesco Ingenito, Rosario Vincenzo Chianese, Francesco Palma

Cancers (Basel)· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-216a Acts as a Negative Regulator of Breast Cancer by Modulating Stemness Properties and Tumor Microenvironment.
Giuseppina Roscigno, Assunta Cirella, Alessandra Affinito, Cristina Quintavalle, Iolanda Scognamiglio, Francesco Ingenito

Int J Mol Sci· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential and Challenges of Aptamers as Specific Carriers of Therapeutic Oligonucleotides for Precision Medicine in Cancer.
Silvia Nuzzo, Giuseppina Roscigno, Alessandra Affinito, Francesco Ingenito, Cristina Quintavalle

Cancers (Basel)· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Exo-miRNAs in Cancer: A Focus on Therapeutic and Diagnostic Applications.
Francesco Ingenito, Giuseppina Roscigno, Alessandra Affinito, Silvia Nuzzo, Iolanda Scognamiglio

Int J Mol Sci· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis